Stockscreener 앱 받기
13.46
0.98%
0.13
전일 마감가:
$13.33
열려 있는:
$13.56
하루 거래량:
285.29K
Relative Volume:
0.64
시가총액:
$936.50M
수익:
$62.71M
순이익/손실:
$-112.51M
주가수익비율:
-8.9139
EPS:
-1.51
순현금흐름:
$-96.01M
1주 성능:
-6.01%
1개월 성능:
+7.94%
6개월 성능:
-7.55%
1년 성능:
+25.21%
1일 변동 폭
$13.42
$13.81
1주일 범위
$13.32
$14.50
52주 변동 폭
$9.03
$17.70
Zymeworks Inc. Stock (ZYME) Company Profile
명칭
Zymeworks Inc.
전화
604-678-1388
주소
1385 West 8th Avenue, Suite 540, Vancouver, BC
ZYME을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
13.46 | 997.68M | 62.71M | -112.51M | -96.01M | -1.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 개시 | TD Cowen | Buy |
| 2024-12-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-11-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | 재개 | Wells Fargo | Overweight |
| 2023-01-04 | 재확인 | H.C. Wainwright | Neutral |
| 2022-12-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | 재개 | Wells Fargo | Overweight |
| 2022-05-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-03-15 | 개시 | Evercore ISI | Outperform |
| 2021-12-10 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | 재개 | Guggenheim | Neutral |
| 2021-10-07 | 개시 | Jefferies | Hold |
| 2021-03-31 | 개시 | Credit Suisse | Outperform |
| 2021-02-25 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | 재개 | H.C. Wainwright | Buy |
| 2021-01-25 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-08-06 | 개시 | SVB Leerink | Outperform |
| 2020-01-10 | 개시 | Wolfe Research | Outperform |
| 2019-12-09 | 개시 | JP Morgan | Neutral |
| 2019-11-25 | 개시 | H.C. Wainwright | Buy |
| 2019-11-20 | 개시 | Guggenheim | Buy |
| 2019-09-30 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | 개시 | Stifel | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2018-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-03-19 | 개시 | Raymond James | Outperform |
모두보기
Zymeworks Inc. 주식(ZYME)의 최신 뉴스
What factors could impact ZYME's future EPS growth? - AInvest
Zymeworks' IND for liver cancer antibody-drug conjugate given FDA clearance - Seeking Alpha
Zymeworks’ second ADC with TOPO1 inhibitor payload to enter clinic in US - BioWorld MedTech
FDA clears Zymeworks’ IND for liver cancer drug candidate ZW251 By Investing.com - Investing.com South Africa
Zymeworks Inc. Advances ZW251 into Clinical Development for Hepatocellular Carcinoma Following IND Clearance from FDA - Quiver Quantitative
FDA Green Lights Revolutionary First-in-Class Liver Cancer Drug: Zymeworks Advances New Treatment - Stock Titan
What catalysts could drive Zymeworks Inc. stock higher in 2025Explosive trading growth - jammulinksnews.com
How does Zymeworks Inc. compare to its industry peersOutstanding trading profits - jammulinksnews.com
How volatile is Zymeworks Inc. stock compared to the marketExponential return rates - jammulinksnews.com
Does Zymeworks Inc. stock perform well during market downturnsCapitalize on fast-growing stocks today - jammulinksnews.com
What are analysts’ price targets for Zymeworks Inc. in the next 12 monthsFree Stock Index Interpretation - jammulinksnews.com
What is Zymeworks Inc. company’s growth strategyGame-changing returns - jammulinksnews.com
When is Zymeworks Inc. stock expected to show significant growthAchieve explosive financial results today - jammulinksnews.com
Will Zymeworks Inc. stock benefit from AI tech trendsFree Advanced Stock Screener Access - jammulinksnews.com
What analysts say about Zymeworks Inc. stockRapid wealth multiplication - Autocar Professional
Zymeworks Inc.'s (NASDAQ:ZYME) Shareholders Might Be Looking For Exit - 富途牛牛
What drives Zymeworks Inc. stock priceFree Market Dynamics Reports - Autocar Professional
Is Zymeworks Inc. a good long term investmentPowerful growth strategies - jammulinksnews.com
Zymeworks Inc. (NYSE:ZYME) Shares Sold by Arizona State Retirement System - Defense World
Zymeworks Announces Pricing of $100.0 Million Public Offering - Finance Monthly
Zymeworks Inc. Stock Analysis and ForecastTremendous gains - jammulinksnews.com
Teacher Retirement System of Texas Cuts Stock Position in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains? - MSN
Zymeworks to Announce Q2 2025 Financials and Engage in Investor Conferences - The Globe and Mail
Zymeworks to Report Second Quarter 2025 Financial Results and Ho - GuruFocus
Zymeworks Inc. to Release Second Quarter 2025 Financial Results on August 7, 2025 - Nasdaq
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire
Zymeworks Sets Q2 Earnings Date, Announces Major Biotech Conference Appearances at BTIG and Stifel - Stock Titan
Zymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
What makes Zymeworks Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser
Zymeworks Inc. (ZYME) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
1.06%
자본화:
|
볼륨(24시간):